Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment?
Thum
Thomas
T
Bauersachs
Johann
J
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D018952:Antigens, CD34 / Q000378:metabolism*; D001854:Bone Marrow Cells / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000473:pathology*; D013234:Stem Cells / Q000166:cytology; D018487:Ventricular Dysfunction, Left / Q000473:pathology
D000806:Angiotensin-Converting Enzyme Inhibitors; D018952:Antigens, CD34; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors